See also this year's filing and all EDGAR filings for this company.
PDF Report 0000874015_2019_Ionis_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 0.8467814163270807, 'aggregate_val': 1548565000, 'exp_sum': 838521000, 'exp_to_value': {'LiabilitiesCurrent': 273005000, 'LiabilitiesNoncurrent': 490060000, 'remainder_Liabilities': 75456000}} |
Graph
Absolute values for 0000874015, Ionis Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,207,886,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 24,032,000 |
| 2 | PropertyPlantAndEquipmentNet | 132,160,000 |
| 3 | remainder_Assets | 303,706,000 |
| 4 | LiabilitiesCurrent | 280,294,000 |
| 5 | LiabilitiesNoncurrent | 567,359,000 |
| 6 | remainder_Liabilities | 632,971,000 |
| 7 | CostOfGoodsAndServicesSold | 1,820,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 924,997,469 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 94,330,215 |
| 11 | remainder_Revenues | 754,812,374 |
| 12 | remainder_NetIncome | 18,572,042 |
| 13 | remainder_ComprehensiveNetIncome | 47,736,970 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,667,784,000 |
| 1 | Liabilities | 1,480,624,000 |
| 2 | Expenses | 1,021,147,684 |
| 3 | Revenues | 754,812,374 |
| 4 | StockholdersEquity | 1,187,160,000 |
| 5 | NetIncome | -247,763,268 |
| 6 | ComprehensiveNetIncome | -223,894,783 |
| 7 | BaseVar | 2,995,338,535 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.14 |
| 9 | EconomicCapitalRatio | 2.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
